| University of Michigan Life Science Corridor Grants | |||||||||||||
| Basic/Applied Research Characterization of Chimeric c-IAP2/MALT-1 in Lymphoma Advanced Simulation of Biomolecular Structure and Dynamics Small Molecule Inhibitors for Lysosomal Storage Disorders Structural Alterations of Proteins in Aging and Disease Laser Based X-Ray Source for High Resolution Mammography Electron-Relay Enabled Immunosensor Apolipoprotein A1 in Atherosclerotic Vascular Disease Identification of a Breast Cancer Initiating Cell PIP2 Effects on Actin, Granule Motion and Exocytosis Hypothalmic Regulation of Pancreatic Secretion Development of a Modified p53 Gene for Human Gene Therapy Transgenic Models of Sodium Channel Beta Subunit Interactions Nuclear Imaging of Met- and HGF/SF-expressing Tumors Molecular Genetics of Atrophic Macular Degeneration Novel Strategy for Mucosal Vaccine Development Development of a Rodent Model for Non-Invasive Imaging of Apoptosis Can Paraoxonase be Used to Treat Endotoxemia and Sepsis? Microarray for Making DNA and RNA Biochips |
$ 629,408 785,055 1,113,588 803,146 965,317 769,589 909,829 1,137,029 738,828 442,326 838,056 676,382 657,450 392,815 1,221,431 868,264 1,740,258 790,262 | ||||||||||||
| Subtotal | $15,479,033 | ||||||||||||
Commercialization/Business Development of U-M Technology Integrated Sensing Systems, Inc. Integrated Sensing Systems, Inc. Nephros Therapeutics, Inc. Thromgen, Inc. Nanobiologics, Inc. Rubicon Genomics, Inc. Molecular Therapeutics, Inc. |
$ 2,750,000 1,978,206 1,061,696 1,172,784 900,007 1,891,242 1,613,179 Subtotal | $ 11,367,114 | Michigan Proteome Consortium (Funded over 5 years) Michigan Center for Biological Information (Funded over 5 years) $ 12,000,000 $ 9,000,000 Total Funding |
$ 47,846,147 | | ||||||||